Abingdon Health Financials
| ABDX Stock | 7.25 0.50 6.45% |
Operating Margin (0.04) | Profit Margin (0.21) | EPS Estimate Current Year (0.03) | Return On Equity (0.49) |
Abingdon | Select Account or Indicator |
Understanding current and past Abingdon Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abingdon Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Abingdon Health's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Abingdon Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abingdon Health Plc. Check Abingdon Health's Beneish M Score to see the likelihood of Abingdon Health's management manipulating its earnings.
Abingdon Health Stock Summary
Abingdon Health competes with Samsung Electronics, Samsung Electronics, Hyundai, Toyota, and Reliance Industries. Abingdon Health is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BLF79J41 |
| Business Address | York Biotech Campus, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abingdonhealth.com |
| Phone | 44 19 0440 6050 |
You should never invest in Abingdon Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abingdon Stock, because this is throwing your money away. Analyzing the key information contained in Abingdon Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abingdon Health Key Financial Ratios
There are many critical financial ratios that Abingdon Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Abingdon Health Plc reports annually and quarterly.| Revenue | 6.13 M | ||||
| Gross Profit | 2.08 M | ||||
| EBITDA | (916 K) | ||||
| Net Income | (1.27 M) | ||||
| Total Asset | 5.09 M |
Abingdon Health Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 7.3M | 11.0M | 33.2M | 12.8M | 6.1M | 5.1M | |
| Retained Earnings | (7.2M) | (10.5M) | (3.0M) | (24.1M) | (27.5M) | (28.8M) | |
| Cash | 866.2K | 4.4M | 5.0M | 2.4M | 3.2M | 1.4M | |
| Net Receivables | 966.5K | 1.5M | 9.1M | 6.7M | 699K | 1.1M | |
| Inventory | 406.4K | 779K | 7.9M | 534K | 329K | 441K | |
| Other Current Assets | 966.5K | 491K | 968K | 1.4M | 498K | 584K | |
| Total Liab | 1.2M | 8.2M | 11.9M | 6.3M | 3.1M | 2.8M | |
| Total Current Assets | 2.2M | 7.2M | 23.0M | 11.0M | 4.8M | 3.5M | |
| Intangible Assets | 779.5K | 16K | 1.2M | 36K | 90K | 153K | |
| Other Current Liab | 1.4M | 6.0M | 944K | 826K | 998K | 1.7M | |
| Net Debt | 383.5K | (3.5M) | (1.1M) | (2.2M) | (391K) | (410.6K) | |
| Accounts Payable | 1.1M | 4.2M | 2.5M | 1.1M | 605K | 574.8K | |
| Net Invested Capital | 6.3M | 21.8M | 7.0M | 3.7M | 4.3M | 4.1M | |
| Net Working Capital | 197.3K | 12.2M | 5.6M | 2.6M | 3.0M | 4.2M | |
| Short Term Debt | 3.5M | 352K | 265K | 87K | 120K | 114K |
Abingdon Health Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (154.3K) | (1.1K) | 19K | (331K) | (105K) | (465.3K) | |
| Interest Income | 3.5K | 1.6K | 234K | 4K | 89K | 678.8K | |
| Interest Expense | 22.4K | 64.3K | 234K | 69K | 72K | 57K | |
| Total Revenue | 2.3M | 5.2M | 11.6M | 2.8M | 4.0M | 6.1M | |
| Gross Profit | 1.6M | 4.1M | 3.4M | (5.2M) | 1.4M | 3.7M | |
| Operating Income | (1.4M) | 217K | (5.5M) | (12.1M) | (3.8M) | (1.4M) | |
| Cost Of Revenue | 705.4K | 1.1M | 8.2M | 8.1M | 2.6M | 2.5M | |
| Income Before Tax | (1.4M) | (3.4M) | (7.1M) | (21.7M) | (3.8M) | (1.4M) | |
| Net Income | (1.3M) | (3.4M) | (7.0M) | (21.3M) | (3.5M) | (1.3M) | |
| Ebit | (3.4M) | (6.8M) | (21.6M) | (3.5M) | (1.3M) | (1.4M) | |
| Research Development | 210.7K | 854K | 503K | 182K | 209.3K | 198.8K | |
| Ebitda | (2.8M) | (6.1M) | (20.0M) | (2.8M) | (916K) | (961.8K) | |
| Income Tax Expense | 1K | (81K) | (423K) | (355K) | (128K) | (134.4K) | |
| Net Interest Income | (62.7K) | (234K) | (65K) | 17K | 19.6K | 20.5K |
Abingdon Health Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 389.2K | 3.5M | 588.8K | (2.6M) | 839K | (1.8M) | |
| Depreciation | 289.1K | 225K | 749K | 1.6M | 673K | 426K | |
| Capital Expenditures | 96.2K | 1.7M | 7.3M | 760K | 157K | 41K | |
| Net Income | (1.3M) | (3.4M) | (7.0M) | (21.3M) | (3.5M) | (1.3M) | |
| End Period Cash Flow | 866.2K | 4.4M | 5.0M | 2.4M | 3.2M | 1.4M | |
| Change To Inventory | (373K) | (7.1M) | (2.3M) | 205K | (112K) | (117.6K) | |
| Free Cash Flow | 445K | (20.1M) | (8.5M) | 845K | (1.7M) | (1.8M) | |
| Other Non Cash Items | 4.0M | 11.2M | 25.9M | (2.2M) | (118K) | (112.1K) | |
| Investments | (1.9M) | (7.3M) | (756K) | (68K) | (78.2K) | (82.1K) |
Abingdon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abingdon Health's current stock value. Our valuation model uses many indicators to compare Abingdon Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abingdon Health competition to find correlations between indicators driving Abingdon Health's intrinsic value. More Info.Abingdon Health Plc is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abingdon Health's earnings, one of the primary drivers of an investment's value.Abingdon Health Plc Systematic Risk
Abingdon Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abingdon Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Abingdon Health Plc correlated with the market. If Beta is less than 0 Abingdon Health generally moves in the opposite direction as compared to the market. If Abingdon Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abingdon Health Plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abingdon Health is generally in the same direction as the market. If Beta > 1 Abingdon Health moves generally in the same direction as, but more than the movement of the benchmark.
Abingdon Health Plc Total Assets Over Time
Abingdon Health Thematic Clasifications
Abingdon Health Plc is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Abingdon Health November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abingdon Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abingdon Health Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abingdon Health Plc based on widely used predictive technical indicators. In general, we focus on analyzing Abingdon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abingdon Health's daily price indicators and compare them against related drivers.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 15.02 | |||
| Value At Risk | (4.29) | |||
| Potential Upside | 3.23 |
Additional Tools for Abingdon Stock Analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.